Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Computable Name: | ||||
version: 2; Last updated: 2026-07-27 13:49:52+0000
Profile: VariableDefinition
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/EvidenceVariable/583771
identifier: FEvIR Object Identifier/583771, FEvIR Linking Identifier/NCT05327010-secondaryOutcome-0
name: Duration_of_response_NCT05327010
title: Duration of response (NCT05327010)
citeAs:
Duration of response (NCT05327010) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 583771. Revised 2026-07-27. Available at: https://fevir.net/resources/EvidenceVariable/583771. Computable resource at: https://fevir.net/resources/EvidenceVariable/583771#json.
status: Active
author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
Assessed using RECIST v1.1.
copyright:
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
| Concept |
| Duration of response Assessed using RECIST v1.1. |
handling: Evidence variable handling not specified
| Text |
| Time from documentation of tumor response to disease progression, assessed up to 2 years |